No Detail Found!

Geniposide attenuates postischemic long-term potentiation via GluN2A

Author(s)
Hua Yao Guangxi Key laboratory of Brain and Cognitive Neuroscience, Guilin Medical University,Guilin,China
Weiqin Liu The Affiliated Ganzhou Hospital of Nanchang University,Nanchang,China
Haikang Liao College of Life and Environmental Sciences, Wenzhou University, China
Tao Sheng Schools of Medicine, Huzhou University, Huzhou Central Hospital, China
Panhong Chen Schools of Medicine, Huzhou University, Huzhou Central Hospital, China
Hongchang Zhou Schools of Medicine, Huzhou University, Huzhou Central Hospital, China; Key Laboratory of Vector Biology and Pathogen Control of Zhejiang Province, Huzhou University, Huzhou Central Hospital, China
Yongliang Pan Schools of Medicine, Huzhou University, Huzhou Central Hospital, China; Key Laboratory of Vector Biology and Pathogen Control of Zhejiang Province, Huzhou University, Huzhou Central Hospital, China
Jinlu Xie Schools of Medicine, Huzhou University, Huzhou Central Hospital, China
Qinghua Zhang Schools of Medicine, Huzhou University, Huzhou Central Hospital, China
Zhenyou Zou Guangxi Key laboratory of Brain and Cognitive Neuroscience, Guilin Medical University,Guilin,China
Zheng Chen Schools of Medicine, Huzhou University, Huzhou Central Hospital, China; Key Laboratory of Vector Biology and Pathogen Control of Zhejiang Province, Huzhou University, Huzhou Central Hospital, China
Abstract
N-Methyl-D-aspartate receptor (NMDAR)-induced antioxidation is a significant cause of neuronal injury after ischemic stroke. In a previous work, we verified the neuroprotective roles of geniposide during tMCAO in vivo. However, it remains unknown whether geniposide ameliorates injury to hippocampal neurons during Ischemic Long Term Potentiation (iLTP) induction in vitro. After induction of cells oxygen-glucose deprivation or hydrogen peroxide, the protection of geniposide evaluated by MTT assay and electrophysiological tests. In this study, we suggested neuronal cell apoptosis was attenuated by geniposide. Furthermore, field excitatory postsynaptic potentials (fEPSCs) following postischemic LTP were assessed by electrophysiological tests. Finally, we determined that medium and high doses of geniposide attenuated oxidative stress insult and improved iLTP. Importantly, these effects were abolished by cotreatment with geniposide and the GluN2A antagonist NVP. In contrast, the GluN2B inhibitor ifenprodil failed to have an effect. In conclusion, we suggest for the first time that treatment with geniposide can attenuate postischemic LTP induction in a concentration-dependent manner. We infer that GluN2A-containing NMDARs are involved in the neuroprotection induced by geniposide treatment in ischemia.
Publication Details
Page(s) 909-914
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
Geniposide, GluN2A, NMDAR, ischemic long-term potentiation, antioxidation
0

Citations

0

Downloads

46

Views